Literature DB >> 16769835

Consequences of verteporfin photodynamic therapy on choroidal neovascular membranes.

Olcay Tatar1, Edwin Kaiserling, Annemarie Adam, Faik Gelisken, Kei Shinoda, Michael Völker, Bart A Lafaut, Karl Ulrich Bartz-Schmidt, Salvatore Grisanti.   

Abstract

OBJECTIVE: To examine the impact of photodynamic therapy (PDT) on angiogenesis in human choroidal neovascular membranes with respect to vascular endothelial growth factor (VEGF) expression, proliferation, and vascularization.
METHODS: Retrospective review of an interventional case series of 50 patients (50 eyes) who underwent removal of choroidal neovascular membranes. Choroidal neovascularization was secondary to age-related macular degeneration. Twenty patients were treated with PDT 3 to 655 days before surgery. Choroidal neovascular membranes were stained for CD34, CD105, Ki-67, cytokeratin 18, and VEGF. Thirty choroidal neovascular membranes secondary to age-related macular degeneration without previous treatment were used as controls.
RESULTS: Specimens without pretreatment disclosed varying degrees of vascularization, proliferative activity, and VEGF expression by different cells. Specimens treated with PDT 3 days earlier showed mostly occluded vessels, damaged endothelial cells, and low proliferative activity. In contrast, specimens excised at later time points after PDT were highly vascularized and proliferating. This chronology was associated with an impressive VEGF immunoreactivity unique to retinal pigment epithelial cells shortly after PDT that also shifted to other cells at later time points.
CONCLUSIONS: Photodynamic therapy induces selective vascular damage in choroidal neovascular membranes. The effectiveness and selectivity of this treatment, however, seem to be jeopardized by a rebound effect initiated by enhanced VEGF expression in retinal pigment epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16769835     DOI: 10.1001/archopht.124.6.815

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  12 in total

1.  Comparison of different treatment intervals between bevacizumab injection and photodynamic therapy in combined therapy for age-related macular degeneration.

Authors:  Miki Sawa; Eiji Iwata; Kohei Ishikawa; Fumi Gomi; Kohji Nishida; Hiroko Terasaki
Journal:  Jpn J Ophthalmol       Date:  2012-06-09       Impact factor: 2.447

2.  Effect of verteporfin photodynamic therapy on endostatin and angiogenesis in human choroidal neovascular membranes.

Authors:  Olcay Tatar; Kei Shinoda; Annemarie Adam; Tillmann Eckert; Claus Eckardt; Klaus Lucke; Christoph Deuter; Karl Ulrich Bartz-Schmidt; Salvatore Grisanti
Journal:  Br J Ophthalmol       Date:  2006-09-20       Impact factor: 4.638

3.  Functional changes following combined intravitreal bevacizumab and photodynamic therapy for polypoidal choroidal vasculopathy.

Authors:  Chengguo Zuo; Feng Wen; Jiaqing Li; Yan Liu; Shixian Long; Shizhou Huang; Meng Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-10-15       Impact factor: 3.117

4.  Classic choroidal neovascularization developing after photodynamic therapy in eyes with polypoidal choroidal vasculopathy.

Authors:  Mitsuhiro Imasawa; Yoichi Sakurada; Hiroyuki Iijima
Journal:  Jpn J Ophthalmol       Date:  2011-05-11       Impact factor: 2.447

5.  Verteporfin photodynamic therapy induced apoptosis in choroidal neovascular membranes.

Authors:  K Petermeier; O Tatar; W Inhoffen; M Völker; B A Lafaut; S Henke-Fahle; F Gelisken; F Ziemssen; S Bopp; K U Bartz-Schmidt; S Grisanti
Journal:  Br J Ophthalmol       Date:  2006-04-13       Impact factor: 4.638

6.  Matrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy.

Authors:  Olcay Tatar; Annemarie Adam; Kei Shinoda; Tillmann Eckert; Gábor B Scharioth; Micheal Klein; Efdal Yoeruek; Karl Ulrich Bartz-Schmidt; Salvatore Grisanti
Journal:  Br J Ophthalmol       Date:  2007-05-02       Impact factor: 4.638

7.  Histopathological findings in postmortem eyes after photodynamic therapy for choroidal neovascularisation in age-related macular degeneration: report of two cases.

Authors:  S J Kang; I Schmack; H E Benson; H E Grossniklaus
Journal:  Br J Ophthalmol       Date:  2007-06-13       Impact factor: 4.638

Review 8.  Polypoidal Choroidal Vasculopathy in Asians.

Authors:  Chee Wai Wong; Tien Y Wong; Chui Ming Gemmy Cheung
Journal:  J Clin Med       Date:  2015-04-24       Impact factor: 4.241

9.  Polypoidal Choroidal Vasculopathy.

Authors:  Joon-Bom Kim; Rajinder S Nirwan; Ajay E Kuriyan
Journal:  Curr Ophthalmol Rep       Date:  2017-04-21

Review 10.  Vascular endothelial growth factor A polymorphisms and age-related macular degeneration: a systematic review and meta-analysis.

Authors:  Chen Huang; Yongsheng Xu; Xuemin Li; Wei Wang
Journal:  Mol Vis       Date:  2013-06-02       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.